Cortagen

Availability on request

Prostamax (KEDP; Lys-Glu-Asp-Pro) is an experimental tetrapeptide from the Khavinson series designed for the prostate. Its primary effects include the regulation of prostate tissue, modulation of inflammation-related processes, influence on chromatin and gene expression, and mitigation of age-related changes in the prostate.

Availability on request

Pancragen (KEDW) is a short peptide targeting the pancreas, developed within the Khavinson system; it is specifically the tetrapeptide Lys-Glu-Asp-Trp (KEDW). Research on this peptide primarily focuses on islet function, insulin and blood glucose metabolism, and age-related decline in pancreatic function. Its key areas of action include islet and pancreatic cell function, blood glucose regulation, insulin metabolism, and age-related pancreatic function.

Availability on request

Testagen (KEDG: Lys-Glu-Asp-Gly) is a tetrapeptide belonging to the Khavinson family; it is primarily marketed as a bioregulatory peptide that supports male reproductive system and testicular function, as well as testosterone production. Its effects include promoting testosterone synthesis, improving male gonadal function, supporting prostate and urinary system health, and regulating DNA and gene expression.

Availability on request

Cardiogen (AEDR; Ala-Glu-Asp-Arg) is a short peptide belonging to the Khavinson system (developed in Russia) that targets the heart and myocardium; its primary function is the bioregulation of myocardial tissue.